Folgen
ilaria marinoni
ilaria marinoni
Group Leader, University of Bern
Bestätigte E-Mail-Adresse bei pathology.unibe.ch
Titel
Zitiert von
Zitiert von
Jahr
Loss of DAXX and ATRX are associated with chromosome instability and reduced survival of patients with pancreatic neuroendocrine tumors
I Marinoni, AS Kurrer, E Vassella, M Dettmer, T Rudolph, V Banz, ...
Gastroenterology 146 (2), 453-460. e5, 2014
4362014
Genetic and epigenetic drivers of neuroendocrine tumours (NET)
A Di Domenico, T Wiedmer, I Marinoni, A Perren
Endocrine-related cancer 24 (9), R315-R334, 2017
1252017
Somatic Mutation and Germline Sequence Abnormalities in CDKN1B, Encoding p27Kip1, in Sporadic Parathyroid Adenomas
J Costa-Guda, I Marinoni, S Molatore, NS Pellegata, A Arnold
The Journal of Clinical Endocrinology & Metabolism 96 (4), E701-E706, 2011
1202011
A novel germline CDKN1B mutation causing multiple endocrine tumors: clinical, genetic and functional characterization
S Molatore, I Marinoni, M Lee, E Pulz, MR Ambrosio, EC Uberti, MC Zatelli, ...
Human mutation 31 (11), E1825-E1835, 2010
1192010
Cyclin-dependent kinase inhibitor 1B (CDKN1B) gene variants in AIP mutation-negative familial isolated pituitary adenoma kindreds
MA Tichomirowa, M Lee, A Barlier, AF Daly, I Marinoni, ML Jaffrain-Rea, ...
Endocrine-Related Cancer 19 (3), 233-241, 2012
942012
Competitive testing of the WHO 2010 versus the WHO 2017 grading of pancreatic neuroendocrine neoplasms: data from a large international cohort study
G Rindi, C Klersy, L Albarello, E Baudin, A Bianchi, MW Buchler, M Caplin, ...
Neuroendocrinology 107 (4), 375-386, 2019
912019
p27kip1: a new multiple endocrine neoplasia gene?
I Marinoni, NS Pellegata
Neuroendocrinology 93 (1), 19-28, 2011
772011
Epigenetic landscape of pancreatic neuroendocrine tumours reveals distinct cells of origin and means of tumour progression
A Di Domenico, CP Pipinikas, RS Maire, K Bräutigam, C Simillion, ...
Communications biology 3 (1), 740, 2020
692020
Autophagy inhibition improves sunitinib efficacy in pancreatic neuroendocrine tumors via a lysosome-dependent mechanism
T Wiedmer, A Blank, S Pantasis, L Normand, R Bill, P Krebs, MP Tschan, ...
Molecular cancer therapeutics 16 (11), 2502-2515, 2017
632017
Characterization of l‐aspartate oxidase and quinolinate synthase from Bacillus subtilis
I Marinoni, S Nonnis, C Monteferrante, P Heathcote, E Härtig, LH Böttger, ...
The FEBS journal 275 (20), 5090-5107, 2008
592008
Functional analysis of MUTYH mutated proteins associated with familial adenomatous polyposis
VG D’Agostino, A Minoprio, P Torreri, I Marinoni, C Bossa, TC Petrucci, ...
DNA repair 9 (6), 700-707, 2010
572010
Transcriptome analysis of MENX-associated rat pituitary adenomas identifies novel molecular mechanisms involved in the pathogenesis of human pituitary gonadotroph adenomas
M Lee, I Marinoni, M Irmler, T Psaras, JB Honegger, R Beschorner, ...
Acta neuropathologica 126, 137-150, 2013
462013
Three-dimensional primary cell culture: a novel preclinical model for pancreatic neuroendocrine tumors
SL April-Monn, T Wiedmer, M Skowronska, R Maire, M Schiavo Lena, ...
Neuroendocrinology 111 (3), 273-287, 2021
412021
ALK7 signaling manifests a homeostatic tissue barrier that is abrogated during tumorigenesis and metastasis
IP Michael, S Saghafinia, M Tichet, N Zangger, I Marinoni, A Perren, ...
Developmental cell 49 (3), 409-424. e6, 2019
362019
YrxA Is the Transcriptional Regulator That Represses De Novo NAD Biosynthesis in Bacillus subtilis
P Rossolillo, I Marinoni, E Galli, A Colosimo, AM Albertini
Journal of bacteriology 187 (20), 7155-7160, 2005
362005
Treatment of advanced gastroenteropancreatic neuroendocrine neoplasia, are we on the way to personalised medicine?
A Rinke, CJ Auernhammer, L Bodei, M Kidd, S Krug, R Lawlor, I Marinoni, ...
Gut 70 (9), 1768-1781, 2021
322021
mTOR inhibitors response and mTOR pathway in pancreatic neuroendocrine tumors
S Falletta, S Partelli, C Rubini, D Nann, A Doria, I Marinoni, V Polenta, ...
Endocrine-related cancer 23 (11), 883-891, 2016
312016
Cancer cells retrace a stepwise differentiation program during malignant progression
S Saghafinia, K Homicsko, A Di Domenico, S Wullschleger, A Perren, ...
Cancer discovery 11 (10), 2638-2657, 2021
28*2021
Hypo-methylation mediates chromosomal instability in pancreatic NET
I Marinoni, A Wiederkeher, T Wiedmer, S Pantasis, A Di Domenico, ...
Endocr. Relat. Cancer 24 (3), 137-146, 2017
282017
Interlaboratory variability of MIB1 staining in well-differentiated pancreatic neuroendocrine tumors
A Blank, L Wehweck, I Marinoni, LA Boos, F Bergmann, AM Schmitt, ...
Virchows Archiv 467, 543-550, 2015
282015
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20